
PAXIL (paroxetine hydrochloride) is indicated in adults for the symptomatic treatment of: Major Depressive Disorder (MDD) Obsessive-Compulsive Disorder (OCD)
GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve …
Jul 2, 2012 · Paxil: In the criminal information, the government alleges that, from April 1998 to August 2003, GSK unlawfully promoted Paxil for treating depression in patients under age 18, even though the FDA has never approved it for pediatric use.
Dolin v. GlaxoSmithKline LLC, No. 17-3030 (7th Cir. 2018)
Aug 22, 2018 · At the time of Stewart’s death, GSK manufactured brand name Paxil and was responsible under federal law for the con tent of the drug’s label. When Stewart died, the labels for par oxetine and similar antidepressant drugs warned that they were associated with suicide in patients under the age of 24.
PAXIL | GSK Canada
July 28, 2005 - Important new safety information (PDF - 36.3 KB) for use of PAXIL and PAXIL CR) on Paroxetine; June 3, 2004 - Health Canada advises Canadians of stronger warnings for SSRIs and other newer anti-depressants; July 15, 2003 - Important safety information (PDF - 29.7 KB) regarding PAXIL in pediatric patients
GlaxoSmithKline prevails in Paxil preemption case as Supreme …
May 29, 2019 · A long-running case over an attorney’s suicide while taking generic versions of GlaxoSmithKline’s Paxil has ended in the drugmaker’s favor, as the U.S. Supreme Court refused to review a lower...
GlaxoSmithKline to Pay $3 Billion in Largest Health Care Fraud ...
Jul 9, 2012 · GSK, one of the world's largest health care and pharmaceuticals companies, admitted to charges that it had promoted antidepressants Paxil and Wellbutrin for uses not approved for by U.S. regulators, including treatment of children and adolescents.
PAXIL is indicated for the symptomatic relief of generalized social phobia (social anxiety disorder), a disorder characterized by marked and persistent fear, anxious anticipation, or avoidance of multiple social situations (e.g. interacting with strangers,
Dolin v. GSK Paxil Suicide Trial | Wisner Baum
Plaintiff Wendy Dolin had filed the lawsuit against GSK in 2012 over the alleged paroxetine-induced wrongful death of her late husband, Stewart Dolin, who was a partner at the law firm Reed Smith and who had committed suicide while taking Paxil as prescribed.
GSK must pay $3 million in generic Paxil suicide lawsuit - U.S. jury
Apr 20, 2017 · GlaxoSmithKline<GSK.L> must pay $3 million (2.34 million pounds) to a woman who sued the drug company over the death of her husband, a lawyer who committed suicide after taking a generic...
Dolin v. GlaxoSmithKline LLC, No. 19-2547 (7th Cir. 2020)
Mar 6, 2020 · Dolin sued GSK, the manufacturer of brand-name Paxil, arguing that GSK was responsible for the labeling for all paroxetine, no matter who made and sold it, and had negligently omitted an adult suicide risk.
- Some results have been removed